nodes	percent_of_prediction	percent_of_DWPC	metapath
Halothane—CYP2B6—Thiotepa—urinary bladder cancer	0.148	0.279	CbGbCtD
Halothane—CYP2A6—Fluorouracil—urinary bladder cancer	0.0738	0.139	CbGbCtD
Halothane—ALB—Fluorouracil—urinary bladder cancer	0.0471	0.0889	CbGbCtD
Halothane—CYP3A4—Thiotepa—urinary bladder cancer	0.0454	0.0857	CbGbCtD
Halothane—CYP2B6—Cisplatin—urinary bladder cancer	0.0408	0.077	CbGbCtD
Halothane—CYP2E1—Etoposide—urinary bladder cancer	0.0407	0.0767	CbGbCtD
Halothane—CYP2B6—Doxorubicin—urinary bladder cancer	0.0274	0.0516	CbGbCtD
Halothane—ALB—Methotrexate—urinary bladder cancer	0.026	0.049	CbGbCtD
Halothane—CYP2C9—Fluorouracil—urinary bladder cancer	0.0254	0.0479	CbGbCtD
Halothane—CYP2C9—Cisplatin—urinary bladder cancer	0.0216	0.0407	CbGbCtD
Halothane—CYP2D6—Doxorubicin—urinary bladder cancer	0.0132	0.0249	CbGbCtD
Halothane—CYP3A4—Etoposide—urinary bladder cancer	0.0123	0.0232	CbGbCtD
Halothane—KCNJ3—prostate gland—urinary bladder cancer	0.0121	0.0464	CbGeAlD
Halothane—RHO—epithelium—urinary bladder cancer	0.0115	0.0441	CbGeAlD
Halothane—GNG2—prostate gland—urinary bladder cancer	0.0101	0.0387	CbGeAlD
Halothane—CYP3A4—Doxorubicin—urinary bladder cancer	0.0084	0.0159	CbGbCtD
Halothane—KCNJ6—female reproductive system—urinary bladder cancer	0.00802	0.0307	CbGeAlD
Halothane—KCNK2—prostate gland—urinary bladder cancer	0.00722	0.0276	CbGeAlD
Halothane—GLRB—prostate gland—urinary bladder cancer	0.00604	0.0231	CbGeAlD
Halothane—GNG2—female reproductive system—urinary bladder cancer	0.00553	0.0211	CbGeAlD
Halothane—KCNK10—renal system—urinary bladder cancer	0.00526	0.0201	CbGeAlD
Halothane—KCNN4—prostate gland—urinary bladder cancer	0.00514	0.0196	CbGeAlD
Halothane—GNG2—vagina—urinary bladder cancer	0.005	0.0191	CbGeAlD
Halothane—ND1—prostate gland—urinary bladder cancer	0.00483	0.0185	CbGeAlD
Halothane—KCNK3—renal system—urinary bladder cancer	0.00475	0.0181	CbGeAlD
Halothane—CYP2C9—urine—urinary bladder cancer	0.00456	0.0174	CbGeAlD
Halothane—KCNN4—seminal vesicle—urinary bladder cancer	0.00435	0.0166	CbGeAlD
Halothane—CYP2E1—urine—urinary bladder cancer	0.00432	0.0165	CbGeAlD
Halothane—KCNMA1—prostate gland—urinary bladder cancer	0.00393	0.015	CbGeAlD
Halothane—ATP5D—prostate gland—urinary bladder cancer	0.00389	0.0149	CbGeAlD
Halothane—ATP2C1—prostate gland—urinary bladder cancer	0.00384	0.0147	CbGeAlD
Halothane—KCNK3—female reproductive system—urinary bladder cancer	0.0038	0.0145	CbGeAlD
Halothane—KCNN4—epithelium—urinary bladder cancer	0.00378	0.0144	CbGeAlD
Halothane—GABRP—prostate gland—urinary bladder cancer	0.00377	0.0144	CbGeAlD
Halothane—KCNN4—smooth muscle tissue—urinary bladder cancer	0.00364	0.0139	CbGeAlD
Halothane—KCNK2—vagina—urinary bladder cancer	0.00356	0.0136	CbGeAlD
Halothane—CYP3A4—urine—urinary bladder cancer	0.00348	0.0133	CbGeAlD
Halothane—KCNN4—urethra—urinary bladder cancer	0.00344	0.0131	CbGeAlD
Halothane—CYP2D6—urine—urinary bladder cancer	0.00342	0.0131	CbGeAlD
Halothane—ND1—smooth muscle tissue—urinary bladder cancer	0.00342	0.0131	CbGeAlD
Halothane—ATP5D—seminal vesicle—urinary bladder cancer	0.00329	0.0126	CbGeAlD
Halothane—ND1—renal system—urinary bladder cancer	0.00329	0.0126	CbGeAlD
Halothane—CYP2A6—prostate gland—urinary bladder cancer	0.00328	0.0125	CbGeAlD
Halothane—ATP2C1—seminal vesicle—urinary bladder cancer	0.00325	0.0124	CbGeAlD
Halothane—GNG2—lymph node—urinary bladder cancer	0.00323	0.0124	CbGeAlD
Halothane—GLRB—vagina—urinary bladder cancer	0.00298	0.0114	CbGeAlD
Halothane—KCNMA1—epithelium—urinary bladder cancer	0.00289	0.011	CbGeAlD
Halothane—GABRE—prostate gland—urinary bladder cancer	0.00288	0.011	CbGeAlD
Halothane—KCNN4—female reproductive system—urinary bladder cancer	0.0028	0.0107	CbGeAlD
Halothane—KCNMA1—smooth muscle tissue—urinary bladder cancer	0.00278	0.0106	CbGeAlD
Halothane—CYP2A6—seminal vesicle—urinary bladder cancer	0.00278	0.0106	CbGeAlD
Halothane—ATP5D—smooth muscle tissue—urinary bladder cancer	0.00276	0.0105	CbGeAlD
Halothane—ATP2C1—smooth muscle tissue—urinary bladder cancer	0.00272	0.0104	CbGeAlD
Halothane—KCNMA1—renal system—urinary bladder cancer	0.00268	0.0102	CbGeAlD
Halothane—ATP5D—renal system—urinary bladder cancer	0.00265	0.0101	CbGeAlD
Halothane—ND1—female reproductive system—urinary bladder cancer	0.00264	0.0101	CbGeAlD
Halothane—ATP2C1—renal system—urinary bladder cancer	0.00262	0.01	CbGeAlD
Halothane—ATP5D—urethra—urinary bladder cancer	0.00261	0.00996	CbGeAlD
Halothane—ATP2C1—urethra—urinary bladder cancer	0.00257	0.00983	CbGeAlD
Halothane—KCNN4—vagina—urinary bladder cancer	0.00254	0.00969	CbGeAlD
Halothane—GABRP—urethra—urinary bladder cancer	0.00252	0.00963	CbGeAlD
Halothane—GRIN2A—vagina—urinary bladder cancer	0.00249	0.0095	CbGeAlD
Halothane—GABRB3—prostate gland—urinary bladder cancer	0.00244	0.00931	CbGeAlD
Halothane—GABRE—seminal vesicle—urinary bladder cancer	0.00243	0.00929	CbGeAlD
Halothane—KCNK2—lymph node—urinary bladder cancer	0.0023	0.0088	CbGeAlD
Halothane—KCNMA1—female reproductive system—urinary bladder cancer	0.00214	0.00819	CbGeAlD
Halothane—ATP5D—female reproductive system—urinary bladder cancer	0.00213	0.00812	CbGeAlD
Halothane—ATP2C1—female reproductive system—urinary bladder cancer	0.0021	0.00801	CbGeAlD
Halothane—GABRB1—vagina—urinary bladder cancer	0.00208	0.00793	CbGeAlD
Halothane—GABRP—female reproductive system—urinary bladder cancer	0.00206	0.00786	CbGeAlD
Halothane—GLRB—lymph node—urinary bladder cancer	0.00193	0.00737	CbGeAlD
Halothane—GABRE—urethra—urinary bladder cancer	0.00193	0.00735	CbGeAlD
Halothane—ATP5D—vagina—urinary bladder cancer	0.00192	0.00734	CbGeAlD
Halothane—ATP2C1—vagina—urinary bladder cancer	0.0019	0.00725	CbGeAlD
Halothane—GABRP—vagina—urinary bladder cancer	0.00186	0.0071	CbGeAlD
Halothane—KCNN4—lymph node—urinary bladder cancer	0.00164	0.00627	CbGeAlD
Halothane—CYP2A6—vagina—urinary bladder cancer	0.00162	0.00619	CbGeAlD
Halothane—GABRE—female reproductive system—urinary bladder cancer	0.00157	0.006	CbGeAlD
Halothane—CYP2E1—prostate gland—urinary bladder cancer	0.00155	0.00592	CbGeAlD
Halothane—ND1—lymph node—urinary bladder cancer	0.00154	0.00589	CbGeAlD
Halothane—GABRA2—vagina—urinary bladder cancer	0.00143	0.00547	CbGeAlD
Halothane—GABRE—vagina—urinary bladder cancer	0.00142	0.00542	CbGeAlD
Halothane—GABRB3—female reproductive system—urinary bladder cancer	0.00133	0.00508	CbGeAlD
Halothane—CYP2E1—seminal vesicle—urinary bladder cancer	0.00131	0.00501	CbGeAlD
Halothane—KCNMA1—lymph node—urinary bladder cancer	0.00125	0.00479	CbGeAlD
Halothane—ATP5D—lymph node—urinary bladder cancer	0.00124	0.00475	CbGeAlD
Halothane—ATP2C1—lymph node—urinary bladder cancer	0.00123	0.00469	CbGeAlD
Halothane—CYP2B6—renal system—urinary bladder cancer	0.00113	0.0043	CbGeAlD
Halothane—CYP2E1—renal system—urinary bladder cancer	0.00106	0.00404	CbGeAlD
Halothane—CYP2E1—urethra—urinary bladder cancer	0.00104	0.00397	CbGeAlD
Halothane—GABRA2—lymph node—urinary bladder cancer	0.000926	0.00354	CbGeAlD
Halothane—GABRE—lymph node—urinary bladder cancer	0.000918	0.00351	CbGeAlD
Halothane—CYP2B6—female reproductive system—urinary bladder cancer	0.000902	0.00345	CbGeAlD
Halothane—CYP2C9—female reproductive system—urinary bladder cancer	0.000893	0.00341	CbGeAlD
Halothane—CYP3A4—renal system—urinary bladder cancer	0.00085	0.00325	CbGeAlD
Halothane—CYP2E1—female reproductive system—urinary bladder cancer	0.000846	0.00323	CbGeAlD
Halothane—ALB—lymph node—urinary bladder cancer	0.000837	0.0032	CbGeAlD
Halothane—CYP2D6—renal system—urinary bladder cancer	0.000837	0.0032	CbGeAlD
Halothane—CYP2B6—vagina—urinary bladder cancer	0.000816	0.00312	CbGeAlD
Halothane—CYP3A4—female reproductive system—urinary bladder cancer	0.000681	0.0026	CbGeAlD
Halothane—CYP2D6—female reproductive system—urinary bladder cancer	0.00067	0.00256	CbGeAlD
Halothane—RHO—Signaling Pathways—CCND1—urinary bladder cancer	4.78e-05	0.000229	CbGpPWpGaD
Halothane—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.75e-05	0.000228	CbGpPWpGaD
Halothane—GABRA5—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.72e-05	0.000227	CbGpPWpGaD
Halothane—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	4.71e-05	0.000226	CbGpPWpGaD
Halothane—GNG2—Metabolism—PPARG—urinary bladder cancer	4.7e-05	0.000226	CbGpPWpGaD
Halothane—ND1—Metabolism—PTGS2—urinary bladder cancer	4.68e-05	0.000225	CbGpPWpGaD
Halothane—ATP5D—Metabolism—PTGS2—urinary bladder cancer	4.68e-05	0.000225	CbGpPWpGaD
Halothane—GABRA6—Neuronal System—HRAS—urinary bladder cancer	4.67e-05	0.000224	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—MMP9—urinary bladder cancer	4.64e-05	0.000223	CbGpPWpGaD
Halothane—GABRA3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.64e-05	0.000223	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—CDKN1A—urinary bladder cancer	4.62e-05	0.000222	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	4.62e-05	0.000222	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—NAT1—urinary bladder cancer	4.62e-05	0.000222	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—PTEN—urinary bladder cancer	4.61e-05	0.000221	CbGpPWpGaD
Halothane—GABRA4—Neuronal System—HRAS—urinary bladder cancer	4.61e-05	0.000221	CbGpPWpGaD
Halothane—ALB—Metabolism—CYP4B1—urinary bladder cancer	4.6e-05	0.000221	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	4.58e-05	0.00022	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—NAT1—urinary bladder cancer	4.58e-05	0.00022	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—KRAS—urinary bladder cancer	4.57e-05	0.000219	CbGpPWpGaD
Halothane—GABRA2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.56e-05	0.000219	CbGpPWpGaD
Halothane—GABRB3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.53e-05	0.000218	CbGpPWpGaD
Halothane—GNG2—Metabolism—CREBBP—urinary bladder cancer	4.51e-05	0.000217	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—NAT2—urinary bladder cancer	4.51e-05	0.000217	CbGpPWpGaD
Halothane—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	4.51e-05	0.000217	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.5e-05	0.000216	CbGpPWpGaD
Halothane—GABRG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.45e-05	0.000214	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—FGFR3—urinary bladder cancer	4.43e-05	0.000213	CbGpPWpGaD
Halothane—GABRA1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.4e-05	0.000211	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—EP300—urinary bladder cancer	4.4e-05	0.000211	CbGpPWpGaD
Halothane—ALB—Hemostasis—IFNA2—urinary bladder cancer	4.39e-05	0.000211	CbGpPWpGaD
Halothane—ALB—Metabolism—SLC19A1—urinary bladder cancer	4.35e-05	0.000209	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—ESR1—urinary bladder cancer	4.31e-05	0.000207	CbGpPWpGaD
Halothane—RHO—Disease—HRAS—urinary bladder cancer	4.3e-05	0.000206	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—SRC—urinary bladder cancer	4.28e-05	0.000205	CbGpPWpGaD
Halothane—ALB—Metabolism—PRSS3—urinary bladder cancer	4.24e-05	0.000204	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	4.22e-05	0.000203	CbGpPWpGaD
Halothane—GABRB2—Neuronal System—HRAS—urinary bladder cancer	4.21e-05	0.000202	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	4.19e-05	0.000201	CbGpPWpGaD
Halothane—GABRA5—Neuronal System—HRAS—urinary bladder cancer	4.09e-05	0.000197	CbGpPWpGaD
Halothane—ND1—Metabolism—PTEN—urinary bladder cancer	4.08e-05	0.000196	CbGpPWpGaD
Halothane—ATP5D—Metabolism—PTEN—urinary bladder cancer	4.08e-05	0.000196	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—TP53—urinary bladder cancer	4.06e-05	0.000195	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—TYMP—urinary bladder cancer	4.02e-05	0.000193	CbGpPWpGaD
Halothane—GABRA3—Neuronal System—HRAS—urinary bladder cancer	4.02e-05	0.000193	CbGpPWpGaD
Halothane—GABRA2—Neuronal System—HRAS—urinary bladder cancer	3.95e-05	0.00019	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—TYMP—urinary bladder cancer	3.94e-05	0.000189	CbGpPWpGaD
Halothane—GABRB3—Neuronal System—HRAS—urinary bladder cancer	3.92e-05	0.000189	CbGpPWpGaD
Halothane—ATP5D—Metabolism—EP300—urinary bladder cancer	3.89e-05	0.000187	CbGpPWpGaD
Halothane—ND1—Metabolism—EP300—urinary bladder cancer	3.89e-05	0.000187	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—RRM2—urinary bladder cancer	3.89e-05	0.000187	CbGpPWpGaD
Halothane—GABRA1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.89e-05	0.000187	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—HRAS—urinary bladder cancer	3.88e-05	0.000186	CbGpPWpGaD
Halothane—GABRG2—Neuronal System—HRAS—urinary bladder cancer	3.85e-05	0.000185	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—MYC—urinary bladder cancer	3.83e-05	0.000184	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	3.8e-05	0.000183	CbGpPWpGaD
Halothane—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	3.78e-05	0.000182	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CREBBP—urinary bladder cancer	3.77e-05	0.000181	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	3.77e-05	0.000181	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—EGFR—urinary bladder cancer	3.75e-05	0.00018	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—IGF1—urinary bladder cancer	3.73e-05	0.000179	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—EGFR—urinary bladder cancer	3.71e-05	0.000178	CbGpPWpGaD
Halothane—GNG2—Metabolism—PTGS2—urinary bladder cancer	3.7e-05	0.000178	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—NAT2—urinary bladder cancer	3.64e-05	0.000175	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—HPGDS—urinary bladder cancer	3.61e-05	0.000173	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—ENO2—urinary bladder cancer	3.61e-05	0.000173	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	3.59e-05	0.000173	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—NAT2—urinary bladder cancer	3.56e-05	0.000171	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	3.56e-05	0.000171	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—KRAS—urinary bladder cancer	3.54e-05	0.00017	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—KRAS—urinary bladder cancer	3.5e-05	0.000168	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	3.5e-05	0.000168	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—GSTT1—urinary bladder cancer	3.5e-05	0.000168	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	3.47e-05	0.000167	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—RHOA—urinary bladder cancer	3.42e-05	0.000164	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.4e-05	0.000163	CbGpPWpGaD
Halothane—ALB—Metabolism—TYMP—urinary bladder cancer	3.39e-05	0.000163	CbGpPWpGaD
Halothane—GABRA1—Neuronal System—HRAS—urinary bladder cancer	3.37e-05	0.000162	CbGpPWpGaD
Halothane—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	3.3e-05	0.000159	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.25e-05	0.000156	CbGpPWpGaD
Halothane—GNG2—Metabolism—PTEN—urinary bladder cancer	3.22e-05	0.000155	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.18e-05	0.000153	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—ERBB2—urinary bladder cancer	3.16e-05	0.000152	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—TP53—urinary bladder cancer	3.15e-05	0.000151	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—RRM2—urinary bladder cancer	3.14e-05	0.000151	CbGpPWpGaD
Halothane—ALB—Hemostasis—PLAU—urinary bladder cancer	3.12e-05	0.00015	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—RRM2—urinary bladder cancer	3.08e-05	0.000148	CbGpPWpGaD
Halothane—GNG2—Metabolism—EP300—urinary bladder cancer	3.07e-05	0.000148	CbGpPWpGaD
Halothane—ALB—Metabolism—NAT2—urinary bladder cancer	3.06e-05	0.000147	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.02e-05	0.000145	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.02e-05	0.000145	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—HRAS—urinary bladder cancer	3.01e-05	0.000145	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CXCL8—urinary bladder cancer	3e-05	0.000144	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—HRAS—urinary bladder cancer	2.98e-05	0.000143	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—ENO2—urinary bladder cancer	2.91e-05	0.00014	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	2.91e-05	0.00014	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—NQO1—urinary bladder cancer	2.91e-05	0.00014	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—IL2—urinary bladder cancer	2.87e-05	0.000138	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	2.85e-05	0.000137	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—ENO2—urinary bladder cancer	2.85e-05	0.000137	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	2.82e-05	0.000136	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—TYMP—urinary bladder cancer	2.8e-05	0.000134	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CCND1—urinary bladder cancer	2.79e-05	0.000134	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.78e-05	0.000134	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—TYMP—urinary bladder cancer	2.77e-05	0.000133	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	2.76e-05	0.000133	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.76e-05	0.000133	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—MMP9—urinary bladder cancer	2.71e-05	0.00013	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CDKN1A—urinary bladder cancer	2.7e-05	0.00013	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—PTEN—urinary bladder cancer	2.7e-05	0.00013	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.66e-05	0.000128	CbGpPWpGaD
Halothane—ALB—Metabolism—RRM2—urinary bladder cancer	2.64e-05	0.000127	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—EP300—urinary bladder cancer	2.57e-05	0.000124	CbGpPWpGaD
Halothane—ALB—Hemostasis—CREBBP—urinary bladder cancer	2.57e-05	0.000123	CbGpPWpGaD
Halothane—ALB—Hemostasis—IGF1—urinary bladder cancer	2.54e-05	0.000122	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—NAT2—urinary bladder cancer	2.53e-05	0.000122	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—NAT2—urinary bladder cancer	2.51e-05	0.00012	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—SRC—urinary bladder cancer	2.5e-05	0.00012	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.49e-05	0.000119	CbGpPWpGaD
Halothane—ALB—Metabolism—ENO2—urinary bladder cancer	2.45e-05	0.000118	CbGpPWpGaD
Halothane—ALB—Metabolism—HPGDS—urinary bladder cancer	2.45e-05	0.000118	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.44e-05	0.000117	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	2.42e-05	0.000116	CbGpPWpGaD
Halothane—ALB—Metabolism—GSTT1—urinary bladder cancer	2.38e-05	0.000114	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.35e-05	0.000113	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—NQO1—urinary bladder cancer	2.35e-05	0.000113	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.34e-05	0.000112	CbGpPWpGaD
Halothane—ALB—Hemostasis—RHOA—urinary bladder cancer	2.32e-05	0.000112	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—NQO1—urinary bladder cancer	2.3e-05	0.00011	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.29e-05	0.00011	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—TYMS—urinary bladder cancer	2.25e-05	0.000108	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—MYC—urinary bladder cancer	2.24e-05	0.000108	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	2.23e-05	0.000107	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	2.23e-05	0.000107	CbGpPWpGaD
Halothane—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.22e-05	0.000107	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—EGFR—urinary bladder cancer	2.19e-05	0.000105	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—RRM2—urinary bladder cancer	2.18e-05	0.000105	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—RRM2—urinary bladder cancer	2.16e-05	0.000104	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—GPX1—urinary bladder cancer	2.13e-05	0.000103	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	2.09e-05	0.000101	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—KRAS—urinary bladder cancer	2.07e-05	9.95e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	2.02e-05	9.72e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—ENO2—urinary bladder cancer	2.02e-05	9.72e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—ENO2—urinary bladder cancer	2e-05	9.63e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	2e-05	9.63e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.99e-05	9.58e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—NQO1—urinary bladder cancer	1.97e-05	9.49e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	1.97e-05	9.46e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	1.96e-05	9.42e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	1.96e-05	9.4e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—IL2—urinary bladder cancer	1.95e-05	9.37e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.94e-05	9.34e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	1.92e-05	9.21e-05	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.92e-05	9.2e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.91e-05	9.2e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—TP53—urinary bladder cancer	1.84e-05	8.84e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.83e-05	8.79e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—TYMS—urinary bladder cancer	1.82e-05	8.74e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	1.8e-05	8.64e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	1.8e-05	8.64e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—TYMS—urinary bladder cancer	1.78e-05	8.56e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	1.76e-05	8.46e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	1.76e-05	8.46e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—HRAS—urinary bladder cancer	1.76e-05	8.45e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—EP300—urinary bladder cancer	1.75e-05	8.41e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—GPX1—urinary bladder cancer	1.72e-05	8.27e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—SRC—urinary bladder cancer	1.7e-05	8.18e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	1.69e-05	8.12e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—GPX1—urinary bladder cancer	1.69e-05	8.1e-05	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.67e-05	8.03e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	1.66e-05	7.95e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.65e-05	7.95e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—GSTP1—urinary bladder cancer	1.65e-05	7.91e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.63e-05	7.83e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.62e-05	7.76e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—PPARG—urinary bladder cancer	1.6e-05	7.67e-05	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.59e-05	7.65e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	1.59e-05	7.63e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.57e-05	7.53e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	1.56e-05	7.48e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	1.53e-05	7.37e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—TYMS—urinary bladder cancer	1.53e-05	7.36e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—NCOR1—urinary bladder cancer	1.51e-05	7.27e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—GSTM1—urinary bladder cancer	1.51e-05	7.27e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—GPX1—urinary bladder cancer	1.45e-05	6.96e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.43e-05	6.86e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—ERCC2—urinary bladder cancer	1.42e-05	6.84e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—KRAS—urinary bladder cancer	1.41e-05	6.77e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.37e-05	6.57e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.36e-05	6.53e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.35e-05	6.48e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—MTHFR—urinary bladder cancer	1.34e-05	6.43e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.32e-05	6.35e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.32e-05	6.35e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.3e-05	6.27e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—PPARG—urinary bladder cancer	1.29e-05	6.19e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.28e-05	6.16e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.26e-05	6.07e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—PPARG—urinary bladder cancer	1.26e-05	6.06e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	1.26e-05	6.04e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.25e-05	6.02e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—TP53—urinary bladder cancer	1.25e-05	6.02e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.25e-05	6e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.25e-05	6e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.24e-05	5.95e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.24e-05	5.95e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	1.24e-05	5.95e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	1.21e-05	5.82e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—HRAS—urinary bladder cancer	1.2e-05	5.75e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.2e-05	5.75e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.19e-05	5.7e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.17e-05	5.64e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.16e-05	5.6e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.1e-05	5.31e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—PTEN—urinary bladder cancer	1.1e-05	5.26e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.09e-05	5.26e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—PPARG—urinary bladder cancer	1.08e-05	5.21e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.07e-05	5.12e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—EP300—urinary bladder cancer	1.04e-05	5.02e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—CREBBP—urinary bladder cancer	1.04e-05	5.01e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	1.01e-05	4.87e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	9.93e-06	4.77e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—PPARG—urinary bladder cancer	8.95e-06	4.3e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	8.89e-06	4.27e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—PPARG—urinary bladder cancer	8.88e-06	4.27e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—PTEN—urinary bladder cancer	8.84e-06	4.25e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—PTEN—urinary bladder cancer	8.66e-06	4.16e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	8.6e-06	4.13e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—PTGS2—urinary bladder cancer	8.53e-06	4.1e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	8.53e-06	4.1e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—EP300—urinary bladder cancer	8.43e-06	4.05e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—TYMS—urinary bladder cancer	8.26e-06	3.97e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—EP300—urinary bladder cancer	8.26e-06	3.97e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	8.17e-06	3.92e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	8.17e-06	3.92e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—GPX1—urinary bladder cancer	7.82e-06	3.76e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	7.68e-06	3.69e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—PTEN—urinary bladder cancer	7.44e-06	3.57e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	7.22e-06	3.47e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—EP300—urinary bladder cancer	7.1e-06	3.41e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	7.04e-06	3.38e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	6.98e-06	3.36e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—PTEN—urinary bladder cancer	6.14e-06	2.95e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—PTEN—urinary bladder cancer	6.09e-06	2.93e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—EP300—urinary bladder cancer	5.86e-06	2.81e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—PPARG—urinary bladder cancer	5.85e-06	2.81e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—EP300—urinary bladder cancer	5.81e-06	2.79e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	5.62e-06	2.7e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	4.61e-06	2.21e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.02e-06	1.93e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.83e-06	1.84e-05	CbGpPWpGaD
